Newsroom
The Latest News From the Ivy Center
The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics.
Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs.
To contact the media relation team, call Melinda Langdon at 623-297-1317 or email: [email protected].
Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog.
Local Foodie News
Phoenix Magazine featured the Ivy Brain Tumor Center's Dine and Donate event for the month of May. The event is a collaboration between the Barrow Neurological Foundation and Hensley Beverage Company to raise money for brain tumor research at the Ivy Brain Tumor Center. Local eateries that participate in the fundraiser will donate a portion of their sales throughout May, or feature a special menu item to support the cause.
Arizona woman who survived a brain tumor takes on Boston Marathon
Christi Endicott, a brave mother of two and brain tumor survivor was featured on AZ Family News sharing her brain tumor survival story. Christi is gearing up to take on the Boston Marathon and highlights her journey and how she persevered through the challenges of brain cancer.
Valley mom says clinical trial saved her life after second battle with glioblastoma
Jenn Ortiz, a mother of two, is celebrating three years of survivorship this August! Her journey with brain cancer began at the Ivy Center when she was diagnosed with glioblastoma. Despite the challenges she's faced, Jenn remains optimistic, inspiring those around her with her perseverance and undeniable sense of humor. Jenn joined ABC15 Arizona to share her story.
Improved Understanding of Genomics Drives Excitement in High-Grade Meningiomas
In OncLive's latest article, they highlight the medical community's increasing interest in how high-grade meningiomas, a common type of brain tumor, might be treated with genomics. Dr. Nader Sanai, at the Ivy Brain Tumor Center, discusses the potential of Phase 0 clinical trials in better testing new treatments for this type of brain cancer.
A New Take on Preclinical Drug Trials for Glioblastoma Treatment
Ivy Center Postdoctoral Fellow Costanza Lo Cascio, PhD, was featured in the latest issue of Oncology Fellows. The article highlights the importance of a pharmacokinetic and pharmacodynamic-guided approach in neuro-oncology preclinical trials to fast-track development of the most promising brain-penetrant drugs for glioblastoma treatment.
Ivy Brain Tumor Center Researcher Wins Grant for Genomic Analysis of Brain Tumors
The Ivy Brain Tumor Center's Pharmacodynamics Core Leader An-Chi Tien has been awarded a one-year, $50,000 grant for work in genetic analysis of meningioma tumors by the American Brain Tumor Association.
Ivy Center Investigator Awarded Grant for High-Risk, High-Impact Brain Cancer Research
Dr. An-Chi Tien, Pharmacodynamics Core Leader of the Ivy Center, is the recipient of the American Brain Tumor Association’s Discovery Grant, a one-year, $50,000 award, supporting faculty and scientists who propose high-risk, high-impact research with the potential to change current diagnostic or treatment models for brain tumor care.
“Health Tomorrow” segment: Brain Surgery
The Ivy Center was featured on Health Tomorrow on PBS’ Arizona Horizon to discuss the challenges facing brain tumor patients and the efforts by the Ivy Center to overcome those obstacles. More brain tumor patients are treated at the Ivy Center and Barrow Neurological Institute than in any other facility in the U.S., explained Dr. Nader Sanai, director of the Ivy Center and director of Neurosurgical Oncology at Barrow Neurological Institute.
SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain Cancer
Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly pediatric brain cancer with a 2% five-year survival rate. To provide therapeutic options for patients and families, SonALAsense is partnering with clinicians at the Ivy Brain Tumor Center at Barrow Neurological Institute, Phoenix Children's Hospital, and other sites to conduct a phase 1/2 clinical trial for sonodynamic therapy (SDT). This is the first SDT trial for children.
Ivy Brain Tumor Center Announces Initial Results of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma at the European Society for Medical Oncology (ESMO) 2022 Congress
Presented today at the ESMO Congress, Dr. Nader Sanai announced initial results in our Phase 0 clinical trial evaluating pamiparib in patients with #glioblastoma (NCT04614909). The interim analysis demonstrated that pamiparib is well-tolerated in glioblastoma patients.